293 related articles for article (PubMed ID: 22208861)
1. Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities.
Gu NY; Botteman MF; Ji X; Bell CF; Carter JA; van Hout B
Health Qual Life Outcomes; 2011 Dec; 9():119. PubMed ID: 22208861
[TBL] [Abstract][Full Text] [Related]
2. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.
Gu NY; Bell C; Botteman MF; Ji X; Carter JA; van Hout B
Patient; 2012; 5(3):185-97. PubMed ID: 22765255
[TBL] [Abstract][Full Text] [Related]
3. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.
Kontodimopoulos N; Bozios P; Yfantopoulos J; Niakas D
Eur J Health Econ; 2013 Apr; 14(2):307-14. PubMed ID: 22252308
[TBL] [Abstract][Full Text] [Related]
5. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
Dakin H; Gray A; Murray D
Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
[TBL] [Abstract][Full Text] [Related]
6. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
7. Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
Khan KA; Petrou S; Rivero-Arias O; Walters SJ; Boyle SE
Pharmacoeconomics; 2014 Jul; 32(7):693-706. PubMed ID: 24715604
[TBL] [Abstract][Full Text] [Related]
8. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis.
Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A
Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838
[TBL] [Abstract][Full Text] [Related]
9. Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom Perspective.
Chalet FX; Bujaroska T; Germeni E; Ghandri N; Maddalena ET; Modi K; Olopoenia A; Thompson J; Togninalli M; Briggs AH
Pharmacoecon Open; 2023 Jan; 7(1):149-161. PubMed ID: 36703022
[TBL] [Abstract][Full Text] [Related]
10. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
[TBL] [Abstract][Full Text] [Related]
11. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
12. Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility.
Park SY; Park EJ; Suh HS; Ha D; Lee EK
J Eval Clin Pract; 2017 Aug; 23(4):755-761. PubMed ID: 28194852
[TBL] [Abstract][Full Text] [Related]
13. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index.
Su J; Liu T; Li S; Zhao Y; Kuang Y
J Med Econ; 2020 Jul; 23(7):737-743. PubMed ID: 32223358
[No Abstract] [Full Text] [Related]
14. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
Pickard AS; Gooderham M; Hartz S; Nicolay C
J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
[TBL] [Abstract][Full Text] [Related]
15. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
[TBL] [Abstract][Full Text] [Related]
16. Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample.
Le QA; Doctor JN
Med Care; 2011 May; 49(5):451-60. PubMed ID: 21422961
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.
Goldsmith KA; Dyer MT; Buxton MJ; Sharples LD
Health Qual Life Outcomes; 2010 Jun; 8():54. PubMed ID: 20525323
[TBL] [Abstract][Full Text] [Related]
18. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
Jia H; Zack MM; Moriarty DG; Fryback DG
Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
[TBL] [Abstract][Full Text] [Related]
19. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
20. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
